Trial Profile
A phase I trial of PfCSP DNA/MVA-CSO prime/boost vaccine in Mampong, Ghana.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Malaria DNA vaccine (Primary) ; Malaria vaccine; Rabies vaccine
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- 08 Dec 2006 New trial record.